z-logo
open-access-imgOpen Access
Clinical features of drug-induced Parkinsonism
Author(s) -
Nobuko Shiraiwa,
Akira Tamaoka,
Norio Ohkoshi
Publication year - 2018
Publication title -
neurology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.39
H-Index - 16
ISSN - 2035-8377
DOI - 10.4081/ni.2018.7877
Subject(s) - medicine , parkinsonism , drug , drug withdrawal , disease , depression (economics) , neurology , medical prescription , pediatrics , psychiatry , pharmacology , economics , macroeconomics
Drug-induced Parkinsonism is often reversible after withdrawal of the causative drug. Its clinical course, however, is not well understood, as the majority of cases are caused by drugs prescribed by departments outside of neurology. We reviewed 21 cases of drug-induced parkinsonism for several factors, including age, sex, causative drug and reason for prescription, department by which it was prescribed, and outcome. The age at onset ranged from 40 to 87 years, with an average Hoehn and Yahr Scale score of 4, indicating severe disability. Sulpiride was the most commonly observed causative drug (71.4%). All causative drugs were prescribed in non-neurological departments and over one half were prescribed in non-psychiatric departments; most were prescribed to treat depression or abdominal discomfort. Ten patients (48%) were previously diagnosed with a neuromuscular disease, including cerebrovascular diseases and Parkinson's disease. Recovery was observed in 15 cases (71%) after withdrawal of the causative drug, but lingering symptoms were observed in the remaining cases. It is suggested that physicians should be more cautious of Parkinsonian side effects when prescribing such drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom